Expression of genes involved in DNA repair and cell cycle checkpoint pathways in Triple Negative compared to Luminal A Breast Cancer: a molecular characterization by Ganzinelli, Monica et al.
MEETING ABSTRACT Open Access
Expression of genes involved in DNA repair and
cell cycle checkpoint pathways in Triple Negative
compared to Luminal A Breast Cancer:
a molecular characterization
Monica Ganzinelli
1, Enilze Ribeiro
2, Ramona Bertoni
3,4, Letizia Bazzola
4, Daniele Andreis
4, Alberto Bottini
4,
Roberto Giardini
3, Camillo Rossi
5, Giovanna Damia
1, Daniele Generali
4*
From Familial Aspects of Cancer 2011 Research and Practice: A combined meeting of kConFab, Australian
Breast Cancer Family Study, Australian Colorectal Cancer Family Study, Australian Ovarian Cancer Study,
Family Cancer Clinics of Australia and New Zealand and kConFab
Kingscliff, Australia. 23-26 August 2011
Purpose
Considering the clear emerging role of the DNA repair
and the cell cycle checkpoints as predictive, prognostic
and therapeutic targets in cancer there is a need to bet-
ter characterized human tumours to define sub-sets of
patients that would benefit of a particular treatment
modality. The aim of the present work is to characterize
molecularly a cohort of Triple Negative Breast Cancers
(TNBC; estrogen receptor negative, progesterone recep-
tor negative, and HER2/neu negative by immunohisto-
chemistry) compared to Luminal A Breast Cancer
(LABC; estrogen receptor positive and/or progesterone
receptor positive, and HER2/neu negative, ki67 expres-
sion < 15% by immunohistochemistry) as regard of gene
expression involved in DNA repair pathway (in particu-
lar genes involved in nucleotide excision repair, base
excision repair, homologous recombination repair and
BRCA/Fanconi anemia pathway) and cell cycle check-
point pathway (CHK1) and their correlation with the
clinical-pathological characteristics.
Experimental design
A single core from archived clinically annotated tumor
specimens from 80 women with TNBC and 70 with
LABC were performed using Tissue Micro Array
machine. The mRNA expression by RT-PCR of in genes
involved in NER pathway (ERCC1, XPA, XPG), in the
FA/BRCA pathway (FANC-A, FANC-C, FANC-F,
FANC-D2), in BER pathway (PARP) and cell cycle
checkpoint (Chk1) were analyzed by RT-PCR. Scores of
single genes were combined with clinical data to assess
association with outcome (Overall Survival –OS- and
Event Free Survival –PFS).
Results
Among the NER genes, ERCC1 (p < 0.0001) and XPA (p
= 0.03) genes were significantly less expressed in TNBC
than in LABC; among the FA genes, BRCA1 (p <
0.0001), FANCD2 (p < 0.0001), FANCF (p < 0.0001)
and PALB2 (p = 0.0006) genes were significantly less
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expressed in TNBC (p < 0.0001).
In relation to the clinical-pathological characteristics,
lower level of XPG and FANCA were associated with
larger tumor size (≥ pT2) at definitive surgery in TNBC.
The high expression of FANCA was related to an
increase of either the Overall Survival (p = 0.0045) or
the Event-Free Survival (p = 0.0141) on univariate analy-
sis in TNBC.
Conclusions
DNA repair and cell cycle checkpoint related genes with
particular regards to ERCC1/XPA in NER family,
BRCA/FANC family and CHK1 may be useful as prog-
nostic markers in TNBC and likely to be important in
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nity. Their determination could be relevant for clinicians
in selecting the proper treatment to adopt in TNBC.
Author details
1Istituto di Ricerche Farmacologiche Mario Negri Milan Italy, Ospedale San
Gerardo, Universita’ di Milano Bicocca Monza, Italy.
2Departamento de
Genética, Setor de Ciencias Biologicas, Universidade Federal do Paraná, Rua
Francisco H. dos Santos, Curitiba, Paranà, Brasil.
3U.O. di Anatomia Patologica,
Istituti Ospitalieri di Cremona, Cremona, Italy.
4U.O. Multidisciplinare di
Patologia Mammaria, Laboratorio di Oncologia Molecolare Senologica, Istituti
Ospitalieri di Cremona, Cremona, Italy.
5Direzione Sanitaria, Istituti Ospitalieri
di Cremona, Cremona, Italy.
Published: 12 April 2012
doi:10.1186/1897-4287-10-S2-A37
Cite this article as: Ganzinelli et al.: Expression of genes involved in DNA
repair and cell cycle checkpoint pathways in Triple Negative compared
to Luminal A Breast Cancer: a molecular characterization. Hereditary
Cancer in Clinical Practice 2012 10(Suppl 2):A37.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ganzinelli et al. Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A37
http://www.hccpjournal.com/content/10/S2/A37
Page 2 of 2